Panorama Medicine, Inc.
October 17, 2023
Franciscan D
CNS/Neurological
Panorama Medicine is a world-leading drug developer in RNA splicing. Our AI-driven platform allows us to explore the vast, untapped RNA space for new modality discovery. We have built a pipeline with both small molecules and antisense oligos (ASOs). We are planning to submit IND for our lead program Pano-777 in infantile encephalopathy by the end of 2023.
Company Type
Privately Funded
Website
http://www.panoramamedicine.com
CEO/Top Company Official
Haishan Xiong
Lead Product in Development
Pano-777 is being developed for STXBP1 encephalopathy, a devastating neuraldevelopmental disorder with no approved treatment
Number Of Unlicensed Products
2
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)